Literature DB >> 19198764

Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Jason M Weaver1, Andrea J Sant.   

Abstract

Immunodominance is a term that reflects the final, very limited peptide specificity of T cells that are elicited during an immune response. Recent experiments in our laboratory compel us to propose a new paradigm for the control of immunodominance in CD4 T cell responses, stating that immunodominance is peptide-intrinsic and is dictated by the off-rate of peptides from MHC class II molecules. Our studies have revealed that persistence of peptide:class II complexes both predicts and controls CD4 T cell immunodominance and that this parameter can be rationally manipulated to either promote or eliminate immune responses. Mechanistically, we have determined that DM editing in APC is a key event that is influenced by the kinetic stability of class II:peptide complexes and that differential persistence of complexes also impacts the expansion phase of the immune response. These studies have important implications for rational vaccine design and for understanding the immunological mechanisms that limit the specificity of CD4 T cell responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19198764     DOI: 10.1007/s12026-009-8095-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  154 in total

Review 1.  The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.

Authors:  H Kropshofer; G J Hämmerling; A B Vogt
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

2.  Sorting of furin in polarized epithelial and endothelial cells: expression beyond the Golgi apparatus.

Authors:  Gaétan Mayer; Guy Boileau; Moïse Bendayan
Journal:  J Histochem Cytochem       Date:  2004-05       Impact factor: 2.479

3.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  MHC class II-restricted presentation of intracellular antigen.

Authors:  S Weiss; B Bogen
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

5.  Modulation of peptide-dependent allospecific epitopes on HLA-DR4 molecules by HLA-DM.

Authors:  S Drover; S Kovats; S Masewicz; J S Blum; G T Nepom
Journal:  Hum Immunol       Date:  1998-02       Impact factor: 2.850

6.  Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10.

Authors:  N Baumgarth; L Brown; D Jackson; A Kelso
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

8.  Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants.

Authors:  Z Liu; K P Williams; Y H Chang; J A Smith
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

Review 9.  Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity.

Authors:  Tatsuya Kanto; Norio Hayashi
Journal:  Intern Med       Date:  2006-03-15       Impact factor: 1.271

10.  Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays.

Authors:  A Sette; J Sidney; M F del Guercio; S Southwood; J Ruppert; C Dahlberg; H M Grey; R T Kubo
Journal:  Mol Immunol       Date:  1994-08       Impact factor: 4.407

View more
  17 in total

1.  Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host.

Authors:  Jennifer L Nayak; Andrea J Sant
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

2.  Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads.

Authors:  Regina S Salvat; Yoonjoo Choi; Alexandra Bishop; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Biotechnol Bioeng       Date:  2015-02-23       Impact factor: 4.530

3.  Computational Evolution Protocol for Peptide Design.

Authors:  Rodrigo Ochoa; Miguel A Soler; Ivan Gladich; Anna Battisti; Nikola Minovski; Alex Rodriguez; Sara Fortuna; Pilar Cossio; Alessandro Laio
Journal:  Methods Mol Biol       Date:  2022

4.  CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.

Authors:  Lichen Jing; Joshua T Schiffer; Tiana M Chong; Joseph J Bruckner; D Huw Davies; Phillip L Felgner; Juergen Haas; Anna Wald; G M G M Verjans; David M Koelle
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

5.  Computationally driven deletion of broadly distributed T cell epitopes in a biotherapeutic candidate.

Authors:  Regina S Salvat; Andrew S Parker; Andrew Guilliams; Yoonjoo Choi; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Cell Mol Life Sci       Date:  2014-06-01       Impact factor: 9.261

6.  Immunology at the university of Rochester.

Authors:  Edith M Lord
Journal:  Immunol Res       Date:  2009-02-25       Impact factor: 2.829

7.  Immune System as a Sensory System.

Authors:  Igor M Dozmorov; D Dresser
Journal:  Int J Biomed Sci       Date:  2010-09-15

8.  Spectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemia.

Authors:  William Klitz; Loren Gragert; Elizabeth Trachtenberg
Journal:  Immunogenetics       Date:  2012-02-15       Impact factor: 2.846

9.  β-Arrestin-2-Dependent Signaling Promotes CCR4-mediated Chemotaxis of Murine T-Helper Type 2 Cells.

Authors:  Rui Lin; Yeon Ho Choi; David A Zidar; Julia K L Walker
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 7.748

10.  Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339.

Authors:  Benjamin M Roy; Dmitriy V Zhukov; Jennifer A Maynard
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.